Patient ID,Age,Gender,Tumor Type,Tumor Grade,Tumor Location,Treatment,Treatment Outcome,Time to Recurrence (months),Recurrence Site,Survival Time (months)
1861,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
354,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
1334,57,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Complete response,,,38
906,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
1290,62,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1274,57,Male,Meningioma,I,Occipital lobe,Radiation,Progressive disease,12.0,Occipital lobe,32
939,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1732,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,14.0,Frontal lobe,42
66,53,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1324,57,Male,Meningioma,I,Occipital lobe,Radiation,Progressive disease,12.0,Occipital lobe,32
57,52,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,60
1293,61,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Temporal lobe,36
1119,48,Female,Meningioma,I,Frontal lobe,Chemotherapy,Progressive disease,16.0,Frontal lobe,28
585,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
375,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
276,68,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,12.0,Frontal lobe,18
747,61,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,14.0,Frontal lobe,30
129,59,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1647,66,Female,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Partial response,14.0,Temporal lobe,24
1853,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
675,46,Male,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,24
1665,65,Female,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,42
1982,65,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Stable disease,20.0,Temporal lobe,28
1084,45,Female,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Partial response,20.0,Temporal lobe,44
1923,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
100,67,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
1180,47,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,44
965,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
793,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,20.0,Temporal lobe,36
30,64,Male,Astrocytoma,II,Frontal lobe,Surgery + Radiation,Partial response,18.0,Frontal lobe,42
629,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
945,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
573,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
908,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1081,64,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,14.0,Frontal lobe,26
451,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1610,63,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Progressive disease,18.0,Occipital lobe,36
1291,55,Female,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Partial response,18.0,Frontal lobe,28
1079,48,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,16.0,Frontal lobe,28
255,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
125,53,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,72
1928,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
252,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,22.0,Temporal lobe,36
586,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1569,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Stable disease,18.0,Frontal lobe,36
825,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
508,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
890,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
71,67,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,30
1609,52,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Complete response,,,42
1533,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
248,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1451,50,Male,Astrocytoma,III,Occipital lobe,Radiation,Progressive disease,16.0,Occipital lobe,28
213,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
910,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
1742,58,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Stable disease,20.0,Occipital lobe,30
1245,55,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,14.0,Occipital lobe,44
1697,65,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,24
1183,61,Female,Meningioma,I,Occipital lobe,Chemotherapy,Complete response,,,38
362,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
1474,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
679,48,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,16.0,Temporal lobe,30
1622,60,Female,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Complete response,,,42
1090,50,Male,Glioblastoma,IV,Parietal lobe,Chemotherapy,Partial response,22.0,Parietal lobe,32
1988,46,Female,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,44
1848,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
988,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1513,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
112,52,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,20.0,Temporal lobe,42
1488,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1454,63,Female,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Stable disease,20.0,Temporal lobe,28
384,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1396,60,Female,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Progressive disease,20.0,Temporal lobe,38
1055,57,Female,Astrocytoma,II,Occipital lobe,Radiation,Progressive disease,20.0,Occipital lobe,38
756,63,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Stable disease,16.0,Occipital lobe,42
325,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1624,56,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Temporal lobe,24
788,58,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Stable disease,20.0,Occipital lobe,30
369,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
1820,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
70,50,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,36
858,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
1484,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
1556,50,Female,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Complete response,,,48
1692,66,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Progressive disease,20.0,Parietal lobe,42
1475,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1799,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
479,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
282,50,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,24
1648,52,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Parietal lobe,30
1557,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Frontal lobe,24
1730,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,30
211,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
298,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1885,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
1834,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
652,60,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
1234,47,Male,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Partial response,18.0,Temporal lobe,44
1503,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1932,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
917,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
994,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
430,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
1371,61,Female,Meningioma,I,Frontal lobe,Chemotherapy,Complete response,,,38
240,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
880,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
621,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
257,53,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,60
612,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Progressive disease,12.0,Occipital lobe,18
545,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
772,58,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,30
1420,49,Female,Astrocytoma,III,Occipital lobe,Chemotherapy,Stable disease,16.0,Occipital lobe,44
1042,49,Female,Meningioma,I,Parietal lobe,Radiation,Progressive disease,18.0,Parietal lobe,32
1790,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
760,53,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Partial response,16.0,Occipital lobe,30
383,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1104,49,Male,Astrocytoma,II,Temporal lobe,Radiation,Stable disease,14.0,Temporal lobe,44
974,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
353,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
1606,60,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
1826,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
1037,56,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1108,65,Male,Meningioma,I,Temporal lobe,Radiation,Stable disease,20.0,Temporal lobe,28
495,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
394,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1547,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
465,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
887,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1194,46,Female,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Partial response,18.0,Temporal lobe,44
367,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
1894,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
1874,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
745,58,Male,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Partial response,18.0,Temporal lobe,36
530,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
803,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1224,60,Male,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,44
1979,54,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,16.0,Frontal lobe,28
1906,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1700,46,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Stable disease,20.0,Parietal lobe,42
1545,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
1314,53,Male,Astrocytoma,III,Parietal lobe,Surgery + Chemotherapy,Stable disease,18.0,Parietal lobe,32
307,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
1667,58,Female,Astrocytoma,II,Frontal lobe,Surgery + Radiation,Stable disease,12.0,Frontal lobe,36
863,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
1567,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,24
531,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
655,52,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Complete response,,,42
1260,59,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,12.0,Parietal lobe,32
234,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
121,68,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,30
1698,53,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,30
950,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
618,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,42
1179,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
308,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
136,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
555,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1674,60,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Partial response,12.0,Temporal lobe,24
584,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1641,54,Male,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,14.0,Occipital lobe,24
671,50,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,20.0,Parietal lobe,42
835,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
110,64,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,72
1165,62,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Stable disease,22.0,Frontal lobe,28
1960,53,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,14.0,Parietal lobe,32
1465,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1729,54,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,20.0,Parietal lobe,24
1243,61,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Progressive disease,12.0,Frontal lobe,32
212,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1768,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
1121,64,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Stable disease,14.0,Frontal lobe,26
680,55,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Partial response,18.0,Frontal lobe,36
1951,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
1839,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
412,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
1325,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,,,36
783,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Progressive disease,20.0,Parietal lobe,24
1346,50,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Complete response,,,38
875,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
1653,53,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Complete response,,,48
1279,53,Female,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Partial response,18.0,Frontal lobe,28
786,65,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Partial response,12.0,Frontal lobe,42
1819,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1199,48,Female,Meningioma,I,Frontal lobe,Chemotherapy,Progressive disease,16.0,Frontal lobe,28
808,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
713,58,Female,Astrocytoma,II,Frontal lobe,Surgery + Radiation,Stable disease,12.0,Frontal lobe,36
1991,56,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1660,55,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,18.0,Parietal lobe,42
1191,50,Male,Astrocytoma,III,Occipital lobe,Chemotherapy,Stable disease,14.0,Occipital lobe,44
1226,57,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Complete response,,,38
603,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Frontal lobe,24
271,68,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,30
1385,50,Male,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Stable disease,24.0,Occipital lobe,38
232,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
50,50,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Partial response,22.0,Temporal lobe,30
463,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1106,57,Male,Glioblastoma,IV,Parietal lobe,Surgery,Complete response,,,38
856,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
694,52,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Parietal lobe,30
1552,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1873,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
527,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
174,60,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,8.0,Temporal lobe,12
721,51,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,36
415,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
238,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
1473,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
1336,59,Male,Meningioma,I,Occipital lobe,Radiation,Stable disease,20.0,Occipital lobe,32
1064,49,Male,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,44
24,56,Male,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Stable disease,24.0,Occipital lobe,36
1767,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
64,47,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,10.0,Frontal lobe,18
290,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
189,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
702,61,Male,Astrocytoma,III,Parietal lobe,Surgery + Radiation,Progressive disease,18.0,Parietal lobe,36
1815,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
1138,55,Female,Astrocytoma,II,Parietal lobe,Radiation,Progressive disease,16.0,Parietal lobe,32
355,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
417,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
1246,65,Male,Meningioma,I,Frontal lobe,Chemotherapy,Progressive disease,16.0,Frontal lobe,28
931,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
197,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
580,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
1135,57,Female,Astrocytoma,II,Occipital lobe,Surgery,Progressive disease,20.0,Occipital lobe,38
1814,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1935,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
434,50,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
101,48,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
1655,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,14.0,Temporal lobe,30
395,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1939,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
221,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
1676,66,Female,Astrocytoma,II,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1498,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
1785,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
345,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
1028,65,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Stable disease,20.0,Temporal lobe,28
889,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
1351,65,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Progressive disease,16.0,Frontal lobe,28
553,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
744,53,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,30
1542,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
539,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
907,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
1395,52,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Partial response,16.0,Frontal lobe,32
116,54,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
830,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
1938,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
809,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
1311,64,Female,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,24.0,Temporal lobe,38
1005,64,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,22.0,Frontal lobe,28
306,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,24
1101,63,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,28
480,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1424,64,Female,Meningioma,I,Occipital lobe,Chemotherapy,Progressive disease,18.0,Occipital lobe,28
1076,53,Female,Glioblastoma,IV,Parietal lobe,Chemotherapy,Progressive disease,12.0,Parietal lobe,32
571,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
619,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
1898,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
1266,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,12.0,Occipital lobe,28
79,45,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,10.0,Parietal lobe,24
1912,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
33,67,Female,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,24
1538,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1034,46,Female,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,44
1563,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Temporal lobe,42
352,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
164,48,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,10.0,Frontal lobe,18
204,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,22.0,Temporal lobe,36
1054,64,Male,Meningioma,I,Parietal lobe,Chemotherapy,Stable disease,18.0,Parietal lobe,32
1365,50,Female,Meningioma,I,Temporal lobe,Radiation,Progressive disease,20.0,Temporal lobe,44
1967,54,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,16.0,Frontal lobe,28
496,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1625,50,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,20.0,Parietal lobe,42
1966,67,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,14.0,Temporal lobe,44
1963,62,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,20.0,Frontal lobe,26
611,55,Male,Meningioma,I,Frontal lobe,Surgery + Radiation,Complete response,,,48
433,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
1492,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
219,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
1931,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1466,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
631,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1382,54,Female,Astrocytoma,III,Occipital lobe,Chemotherapy,Stable disease,18.0,Occipital lobe,44
1302,58,Male,Astrocytoma,II,Occipital lobe,Chemotherapy,Stable disease,20.0,Occipital lobe,32
60,63,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,72
299,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1711,56,Male,Astrocytoma,III,Temporal lobe,Surgery + Chemotherapy,Complete response,,,30
74,59,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,8.0,Temporal lobe,12
163,70,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,48
1275,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,,,36
1594,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
1434,53,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Complete response,,,38
1613,65,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,24
592,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
317,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
46,49,Male,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Stable disease,12.0,Occipital lobe,18
1720,48,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,42
1832,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
428,61,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
582,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
77,47,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,42
1917,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1415,50,Male,Meningioma,I,Occipital lobe,Chemotherapy,Progressive disease,14.0,Occipital lobe,28
781,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Stable disease,12.0,Temporal lobe,36
1920,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
1174,64,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,18.0,Parietal lobe,32
1320,50,Male,Astrocytoma,III,Occipital lobe,Radiation,Progressive disease,16.0,Occipital lobe,28
938,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
31,58,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Complete response,,,60
1092,67,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,14.0,Temporal lobe,44
1616,46,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,42
1230,58,Male,Meningioma,I,Parietal lobe,Chemotherapy,Complete response,,,38
975,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
1085,62,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Stable disease,22.0,Frontal lobe,28
515,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
1551,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1568,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
1811,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
1574,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
45,55,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,48
1687,59,Male,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Stable disease,18.0,Temporal lobe,30
169,62,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,60
304,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,22.0,Temporal lobe,36
991,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
556,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
1925,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
608,54,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1619,59,Male,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Complete response,,,36
758,50,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,18.0,Parietal lobe,36
439,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
583,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1519,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
528,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
343,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
1737,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Progressive disease,20.0,Parietal lobe,24
368,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
186,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
1117,56,Female,Meningioma,I,Occipital lobe,Chemotherapy,Complete response,,,38
1755,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1426,53,Female,Astrocytoma,III,Frontal lobe,Chemotherapy,Stable disease,16.0,Frontal lobe,44
301,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1904,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
833,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
544,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
1601,61,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,48
351,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1933,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1511,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
979,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
176,68,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,12.0,Frontal lobe,18
483,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1413,63,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,12.0,Parietal lobe,38
1611,56,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
124,60,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,8.0,Temporal lobe,12
600,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
1795,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
1746,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Stable disease,16.0,Occipital lobe,30
1379,64,Male,Astrocytoma,III,Frontal lobe,Radiation,Stable disease,22.0,Frontal lobe,28
1186,57,Male,Glioblastoma,IV,Parietal lobe,Chemotherapy,Complete response,,,38
486,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
332,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
789,46,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
195,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
638,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
472,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1714,53,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Partial response,16.0,Occipital lobe,30
323,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1197,56,Female,Meningioma,I,Occipital lobe,Chemotherapy,Complete response,,,38
267,59,Female,Astrocytoma,II,Parietal lobe,Surgery,Partial response,22.0,Parietal lobe,42
1544,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
1804,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
68,45,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1738,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Stable disease,18.0,Occipital lobe,30
1593,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
1564,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,16.0,Parietal lobe,24
481,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
1757,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1913,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1441,59,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,12.0,Parietal lobe,32
1461,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
888,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
423,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1675,51,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,36
1450,55,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,44
765,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,36
520,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
1432,61,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Progressive disease,16.0,Frontal lobe,28
614,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
1531,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
1783,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
1659,48,Female,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Progressive disease,16.0,Temporal lobe,36
454,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
731,61,Male,Astrocytoma,III,Parietal lobe,Surgery + Radiation,Progressive disease,20.0,Parietal lobe,24
535,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
966,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
1285,63,Female,Astrocytoma,III,Temporal lobe,Surgery + Chemotherapy,Partial response,18.0,Temporal lobe,44
1740,65,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Partial response,12.0,Frontal lobe,42
262,52,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,20.0,Temporal lobe,42
536,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
